Want to join the conversation?
U.S. drug delivery firm $CTLT said that 4Q16 revenue rose 4% as reported and rose 6% in constant currency to $532MM, all of which was organic, with all segments contributing to the growth. For full-year 2016, the company recorded revenue growth of 6% at a constant currency vs. 2015, despite the challenges related to Beinheim facility suspension.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.